Drug Profile


Alternative Names: Azithromycin/chloroquine; Chloroquine/Zithromax; Zithromax/chloroquine

Latest Information Update: 05 Mar 2014

Price : $50

At a glance

  • Originator Pfizer
  • Class Aminoquinolines; Antimalarials; Macrolides
  • Mechanism of Action Hemozoin inhibitors; Ribonucleoprotein inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • On Fast track

    Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.

  • New Molecular Entity No

Highest Development Phases

  • Discontinued Malaria

Most Recent Events

  • 28 Feb 2014 Discontinued - Phase-III for Malaria in Kenya (PO)
  • 28 Feb 2014 Discontinued - Phase-III for Malaria in Uganda (PO)
  • 28 Feb 2014 Discontinued - Phase-II/III for Malaria in West Africa (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top